{"id":332622,"date":"2026-10-29T15:59:57","date_gmt":"2026-10-29T10:29:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/senores-pharmaceuticals-l-q2-results-fy27-pat-8-crore\/"},"modified":"2026-10-29T15:59:57","modified_gmt":"2026-10-29T10:29:57","slug":"senores-pharmaceuticals-l-q2-results-fy27-pat-8-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/senores-pharmaceuticals-l-q2-results-fy27-pat-8-crore\/","title":{"rendered":"SENORES PHARMACEUTICALS L Q2 Results FY27: PAT Falls 76.16% to Rs 7.72 Cr, Revenue Rs 35.65 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

SENORES PHARMACEUTICALS L<\/a> Q2 Results FY27 were declared on 29 October 2026 with revenue of Rs 35.65 Cr, down 77.96% YoY from Rs 161.76 Cr, and net profit of Rs 7.72 Cr, down 76.16% from Rs 32.38 Cr. In these quarterly results, both lines show negative YoY growth against the year-ago quarter, and net profit fell slightly less than revenue. The comparison quarter is July to September 2025.<\/p>\n<\/div>\n

SENORES PHARMACEUTICALS L (SENORES) Q2 Results FY27 announced on 29 October 2026, covering the company’s financial performance for the July to September quarter. On the results date, revenue came in at Rs 35.65 Cr and net profit at Rs 7.72 Cr, both below the year-ago quarter. SENORES PHARMACEUTICALS L Q2 Results FY27 are the base for everything that follows.<\/p>\n

This SENORES PHARMACEUTICALS L Q2 Results analysis by Univest covers the financial highlights, business drivers, outlook and risks. The results analysis starts with the highlights table below, which lists revenue and net profit for the quarter and for the year-ago period, so the YoY growth figures can be read directly.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n